SciELO - Scientific Electronic Library Online

 
vol.139 issue7Relative bioavailability study of two oral formulations of mycophenolate mofetil in healthy volunteersMyeloid sarcoma: Report of one case with trisomy 11 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

VEGA, Jorge; GOECKE, Helmuth; RODRIGUEZ, Mª De Los Ángeles  and  VERGARA, Mª Teresa. Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: Report of one case. Rev. méd. Chile [online]. 2011, vol.139, n.7, pp.909-913. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872011000700012.

Chronic hemodialysis patients may have recurrent bleeding from gastrointestinal angiodysplasia, that often is diffusely located in the digestive tract or in places difficult to reach with traditional endoscopes. Therefore, they cannot be locally treated or removed. We report a 70 years old man on chronic hemodialysis, with severe and persistent anemia due to bleeding from angiodysplasia of the small bowel. Despite administration of high doses of erythropoiesis stimulating agents, intravenous iron, folate, B6 and B12 vitamins, his hemoglobin levels were < 6.5g/dL, becoming totally dependent on transfusions ofred blood cells (up to 46 units per year). Recurrent bleeding was refractory to conventional management and we decided to use thalidomide at doses of 50-100 mg/day achieving rapid control of gastrointestinal bleeding and significant increase of hemoglobin levels, not requiring further transfusions.

Keywords : Angiodysplasia; Renal dialysis; Thalidomide.

        · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License